Doctor of Osteopathy Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Dennis Devinney

Orthopaedic Surgery Tyler, TX Doctor of Osteopathy

NPI 1457398935 CMS profile 202190

700 Olympic Plaza Cir, Suite 600, Tyler, TX 75701

Open in the dashboard

General payments

$267,120

236 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Dennis Devinney of Tyler, TX is reported in the CMS Open Payments database as having received $267,120 across 236 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 95th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $41,015 39
2024 General $44,015 17
2023 General $42,840 71
2022 General $33,750 27
2021 General $41,621 30
2020 General $30,001 29
2019 General $33,879 23

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Dennis Devinney
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Dennis Devinney were reported at $41,015. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Dennis Devinney Orthopaedic Surgery median Middle half National median
2019 $33,879 $644 $140–$2,844 $163
2020 $30,001 $312 $75–$1,860 $114
2021 $41,621 $520 $117–$2,495 $132
2022 $33,750 $598 $128–$2,731 $149
2023 $42,840 $461 $128–$2,264 $160
2024 $44,015 $497 $134–$2,475 $164
2025 $41,015 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Arthrex, Inc. $145,261 81 payments
  2. Stryker Corporation $54,260 67 payments
  3. Wright Medical Technology, Inc. $31,401 14 payments
  4. Advanced Orthopaedic Solutions, Inc. $26,274 9 payments
  5. Encore Medical, LP $6,300 2 payments
  6. Pylant Medical $2,677 20 payments
  7. Bioventus LLC $366 20 payments
  8. Ferring Pharmaceuticals Inc. $158 4 payments
  9. Ablative Solutions, Inc. $77 1 payment
  10. Medtronic, Inc. $60 1 payment
  11. Other $287 17 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Royalty or License $244,974 65 payments
  2. Travel and Lodging $9,537 28 payments
  3. Consulting Fee $6,300 2 payments
  4. Food and Beverage $4,892 137 payments
  5. Education $1,417 4 payments
Products named General payments · program years 2019–2025
  1. AEQUALIS PERFORM $47,915 24 payments
  2. AEQUALIS $31,401 14 payments
  3. AOS HUMERAL NAIL 7.0MM X 25CM $18,411 3 payments
  4. AOS PROXIMAL HUMERAL NAIL 8.0MM X 15CM $18,411 3 payments
  5. HUMERAL NAIL SYSTEM $15,148 5 payments
  6. AOS PRODUCTS Orthopedic $7,864 3 payments
  7. AOS PRODUCTS Aos Products $3,262 1 payment
  8. DJO Surgical AltiVate Reverse Joint Implants $3,150 1 payment
  9. DJO Surgical AltiVate Reverse Joint Implants $3,150 1 payment
  10. BLUEPRINT PATIENT SPECIFIC INSTRUMENTATION $3,130 13 payments
  11. Other $4,657 86 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 7 drugs

Part D claims

263

Median for Orthopedic Surgery: 203

Drug cost

$2,997

Median for Orthopedic Surgery: $1,433

Branded share of claims

30.4%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Celecoxib Generic 120 $1,879
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 58 $635
Acetaminophen-Codeine Acetaminophen With Codeine Brand 22 $297
Clindamycin Hcl Generic 18 $74
Cyclobenzaprine Hcl Generic 14 $71
Meloxicam Generic 12 $23
Amoxicillin Generic 19 $17

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 85 billing codes

Paid by Medicare

$158,126

Medicare's payments for the services billed

Medicare patients

351

Average age 73

Services billed

1,216

184 women, 167 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Diabetes 32%
Ischemic heart disease 32%
Depression 30%
COPD 26%
Chronic kidney disease 23%
Atrial fibrillation 21%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

236 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record